These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 26338232)

  • 1. Approaches to the Development of Human Health Toxicity Values for Active Pharmaceutical Ingredients in the Environment.
    Sorell TL
    AAPS J; 2016 Jan; 18(1):92-101. PubMed ID: 26338232
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A compilation of safety impact information for extractables associated with materials used in pharmaceutical packaging, delivery, administration, and manufacturing systems.
    Jenke D; Carlson T
    PDA J Pharm Sci Technol; 2014; 68(5):407-55. PubMed ID: 25336416
    [TBL] [Abstract][Full Text] [Related]  

  • 3. It is time to develop ecological thresholds of toxicological concern to assist environmental hazard assessment.
    Belanger SE; Sanderson H; Embry MR; Coady K; DeZwart D; Farr BA; Gutsell S; Halder M; Sternberg R; Wilson P
    Environ Toxicol Chem; 2015 Dec; 34(12):2864-9. PubMed ID: 26111584
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Threshold of toxicological concern for chemical substances present in the diet: a practical tool for assessing the need for toxicity testing.
    Kroes R; Galli C; Munro I; Schilter B; Tran L; Walker R; Würtzen G
    Food Chem Toxicol; 2000; 38(2-3):255-312. PubMed ID: 10717364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Thresholds of Toxicological Concern - Setting a threshold for testing below which there is little concern.
    Hartung T
    ALTEX; 2017; 34(3):331-351. PubMed ID: 28735337
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The Threshold of Toxicological Concern (TTC) is a pragmatic tool for the safety assessment: Case studies of cosmetic ingredients with low consumer exposure.
    Bury D; Head J; Keller D; Klaric M; Rose J;
    Regul Toxicol Pharmacol; 2021 Jul; 123():104964. PubMed ID: 34023455
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Managing emissions of active pharmaceutical ingredients from manufacturing facilities: an environmental quality standard approach.
    Murray-Smith RJ; Coombe VT; Grönlund MH; Waern F; Baird JA
    Integr Environ Assess Manag; 2012 Apr; 8(2):320-30. PubMed ID: 22057894
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Toxicity assessment strategies, data requirements, and risk assessment approaches to derive health based guidance values for non-relevant metabolites of plant protection products.
    Dekant W; Melching-Kollmuss S; Kalberlah F
    Regul Toxicol Pharmacol; 2010 Mar; 56(2):135-42. PubMed ID: 19883711
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Utilizing relative potency factors (RPF) and threshold of toxicological concern (TTC) concepts to assess hazard and human risk assessment profiles of environmental metabolites: a case study.
    Terry C; Rasoulpour RJ; Knowles S; Billington R
    Regul Toxicol Pharmacol; 2015 Mar; 71(2):301-17. PubMed ID: 25584438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure-based thresholds of toxicological concern (TTC): guidance for application to substances present at low levels in the diet.
    Kroes R; Renwick AG; Cheeseman M; Kleiner J; Mangelsdorf I; Piersma A; Schilter B; Schlatter J; van Schothorst F; Vos JG; Würtzen G;
    Food Chem Toxicol; 2004 Jan; 42(1):65-83. PubMed ID: 14630131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modeling pharmaceutical emissions and their toxicity-related effects in life cycle assessment (LCA): A review.
    Emara Y; Lehmann A; Siegert MW; Finkbeiner M
    Integr Environ Assess Manag; 2019 Jan; 15(1):6-18. PubMed ID: 30242966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.
    EFSA GMO Panel Working Group on Animal Feeding Trials
    Food Chem Toxicol; 2008 Mar; 46 Suppl 1():S2-70. PubMed ID: 18328408
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Point of departure (PoD) selection for the derivation of acceptable daily exposures (ADEs) for active pharmaceutical ingredients (APIs).
    Bercu JP; Morinello EJ; Sehner C; Shipp BK; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S48-56. PubMed ID: 27233925
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of novel uncertainty factors and thresholds of toxicological concern for health hazard and risk assessment: Application to cleaning product ingredients.
    Wang Z; Scott WC; Williams ES; Ciarlo M; DeLeo PC; Brooks BW
    Environ Int; 2018 Apr; 113():357-376. PubMed ID: 29452931
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Environmental risk assessment of pharmaceutical drug substances--conceptual considerations.
    Länge R; Dietrich D
    Toxicol Lett; 2002 May; 131(1-2):97-104. PubMed ID: 11988362
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Critical analysis of literature on low-dose synergy for use in screening chemical mixtures for risk assessment.
    Boobis A; Budinsky R; Collie S; Crofton K; Embry M; Felter S; Hertzberg R; Kopp D; Mihlan G; Mumtaz M; Price P; Solomon K; Teuschler L; Yang R; Zaleski R
    Crit Rev Toxicol; 2011 May; 41(5):369-83. PubMed ID: 21309635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A harmonization effort for acceptable daily exposure application to pharmaceutical manufacturing - Operational considerations.
    Hayes EP; Jolly RA; Faria EC; Barle EL; Bercu JP; Molnar LR; Naumann BD; Olson MJ; Pecquet AM; Sandhu R; Shipp BK; Sussman RG; Weideman PA
    Regul Toxicol Pharmacol; 2016 Aug; 79 Suppl 1():S39-47. PubMed ID: 27267172
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Health related guide values for drinking-water since 1993 as guidance to assess presence of new analytes in drinking-water.
    Dieter HH
    Int J Hyg Environ Health; 2014 Mar; 217(2-3):117-32. PubMed ID: 23820379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Minderoo-Monaco Commission on Plastics and Human Health.
    Landrigan PJ; Raps H; Cropper M; Bald C; Brunner M; Canonizado EM; Charles D; Chiles TC; Donohue MJ; Enck J; Fenichel P; Fleming LE; Ferrier-Pages C; Fordham R; Gozt A; Griffin C; Hahn ME; Haryanto B; Hixson R; Ianelli H; James BD; Kumar P; Laborde A; Law KL; Martin K; Mu J; Mulders Y; Mustapha A; Niu J; Pahl S; Park Y; Pedrotti ML; Pitt JA; Ruchirawat M; Seewoo BJ; Spring M; Stegeman JJ; Suk W; Symeonides C; Takada H; Thompson RC; Vicini A; Wang Z; Whitman E; Wirth D; Wolff M; Yousuf AK; Dunlop S
    Ann Glob Health; 2023; 89(1):23. PubMed ID: 36969097
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Environmental risk assessment for new human pharmaceuticals in the European Union according to the draft guideline/discussion paper of January 2001.
    Straub JO
    Toxicol Lett; 2002 Oct; 135(3):231-7. PubMed ID: 12270681
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.